Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Successive emergence of two CD8 subsets in primary CMV infection of allograft recipientsM Labalette, F Salez, F R Pruvot, et al.
Clinical and Experimental Immunology|March 1, 1994
CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cellsM Labalette, F Salez, F R Pruvot, et al.
International Immunology|July 28, 1999
Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expressionM Labalette, E Leteurtre, C Thumerelle, et al.
Transplantation|June 27, 1995
Implication of cyclosporine in up-regulation of Bcl-2 expression and maintenance of CD8 lymphocytosis in cytomegalovirus-infected allograft recipientsM Labalette, V Queyrel, E Masy, et al.
Transplantation Proceedings|October 28, 2009
Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignanciesF Glowacki, M Al Morabiti, A Lionet, et al.
Presse Medicale (Paris, France : 1983)|December 2, 1992
[Incidence and clinical expressions of microvascular complications in patients receiving kidney graft and treated with cyclosporine]C Noël, P Saunier, M Labalette-Houache, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|December 9, 2000
Prolongation of cardiac allograft survival by selective injection of donor liver leukocytes in non-immunosuppressed ratsR Sfeir, L Gambiez, M Labalette, et al.
Transplantation|April 13, 2000
Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion moleculesC Noel, M C Copin, M Hazzan, et al.
Transplantation|March 4, 1998
Improvement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trialC Noel, M Hazzan, M Labalette, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 1, 1996
CD28 expression is increased in venom allergic patients but is not modified by specific immunotherapyA Tsicopoulos, M Labalette, H Akoum, et al.
Pageof 4